Jeff Liu holds a PhD in oncology from Oxford and previously founded Vivid Dx, which developed a diagnostic approach for sepsis that reduced testing time from five days to thirty minutes. He is now CEO of FinalDose, a YC-backed company.
Intro paths
YC
Jeff went through Y Combinator (Spring 2026) — any YC alum in your network can reach them through the YC community.
→
In turn, Jeff can intro founders to FinalDose's investors below.
FinalDose's investors · 1
Co-founders
Li-Yao Huang· FounderSteven Lin· Founder